Table 2 Prevalence estimates of depression, anxiety and resilience (as measured by PHQ 9, GAD-7 and CD-RISC 10 scales) among the participants by covid-19 impact
Psychometric property | Impacted by Covid-19Â N (%) | Not Impacted by Covid-19Â N (%) | Total sample N (%) |
|---|---|---|---|
Depression as measured by PHQ-9 | |||
Minimal to mild depression (score ≤ 9) | 398 (56.2) | 74 (82.2) | 472 (59.1) |
Moderate to severe depression (score ≥ 10) | 310 (43.8) | 16 (17.8) | 326 (40.9) |
Anxiety as measured by GAD-7 | |||
Minimal to mild anxiety (score ≤ 9) | 424 (59.9) | 62 (68.9) | 486 (60.9) |
Moderate to severe anxiety (Score ≥ 10) | 284 (40.1) | 28 (31.8) | 312 (39.1) |
Resilience as measured by CD-RISC-10 | |||
Low to normal resilience (≤ 32) | 631 (89.1) | 75 (83.3) | 706 (88.5) |
High resilience (score ≥ 33) | 77 (10.9) | 15 (16.7) | 92 (11.5) |
Total | 708 (100) | 90 (100) | 798 (100) |